Psilocybin-assisted therapy Orlando residents are increasingly asking about — and for good reason. Research into psychedelic-assisted therapy has expanded dramatically over the past decade, and psilocybin in particular has emerged as one of the most promising tools for people struggling with depression, anxiety, PTSD, and existential distress.
At Achieve Growth Therapy, we work with adults seeking psilocybin-assisted therapy in Orlando and across Florida who want to understand the science, or are ready to explore whether it’s an appropriate part of their healing journey. This page is designed to give you a thorough, honest, clinically-informed overview of what psilocybin therapy is — and what it isn’t.
Important note: As of 2026, psilocybin remains a Schedule I controlled substance at the federal level. Florida does not currently have a legal framework for therapeutic psilocybin use outside of clinical research settings. We do not administer psilocybin. Our clinicians provide preparation, integration, and harm reduction support within the bounds of Florida law.
What You’ll Learn on This Page
- What Is Psilocybin-Assisted Therapy?
- What Does the Research Show?
- How Does Psilocybin Work in the Brain?
- What Is Psilocybin Therapy Like?
- Who Is a Good Candidate?
- The Legal Landscape in Florida (2026)
- How to Find a Qualified Therapist in Orlando
- Psilocybin Integration Therapy
- Frequently Asked Questions
What Is Psilocybin-Assisted Therapy?
Psilocybin is a naturally occurring psychedelic compound found in certain species of fungi — commonly called “magic mushrooms.” When ingested, it converts to psilocin in the body and produces shifts in perception, emotion, and cognition that can last four to six hours. In a therapeutic context, these experiences are carefully structured and supported by trained clinicians.
Psilocybin-assisted therapy Orlando and elsewhere is not the same as recreational use. It is a structured protocol typically involving three phases:
- Preparation sessions — building therapeutic alliance, setting intentions, screening for contraindications
- The dosing session — taking psilocybin in a supported, clinically supervised environment
- Integration sessions — making meaning of the experience, translating insights into lasting behavioral and psychological change
The therapy component is not incidental to psilocybin-assisted therapy Orlando. Research consistently shows that the quality of the therapeutic relationship and the integration work done after the experience are as important to outcomes as the experience itself.
Psilocybin vs. Other Psychedelic Therapies
Psilocybin is one of several substances being studied in the emerging field of psychedelic-assisted therapy. Others include MDMA (currently in FDA Phase 3 trials for PTSD), ketamine (legal and available in many clinical settings, including through integration-focused therapy), LSD, and ayahuasca. Each has a distinct mechanism of action, risk profile, duration, and therapeutic application. Psilocybin’s relatively short duration (4–6 hours vs. 12+ for LSD or ayahuasca), its comparatively benign physiological safety profile, and the volume of clinical research behind it make it particularly interesting to researchers and clinicians.
What Does the Research Show?
The past decade has produced a remarkable body of peer-reviewed research on psilocybin. Here is a summary of the strongest evidence to date:
Treatment-Resistant Depression
Studies at Johns Hopkins University, Imperial College London, and NYU have demonstrated significant reductions in depressive symptoms following psilocybin-assisted therapy, including in patients who had not responded to multiple antidepressant treatments. The 2021 COMPASS Pathways Phase IIb trial, the largest controlled trial to date, showed that a 25mg dose produced significant symptom reduction in treatment-resistant depression with a durable response at 12 weeks.
End-of-Life Anxiety and Existential Distress
Some of the earliest modern research focused on patients facing terminal illness. Studies at NYU and Johns Hopkins found that psilocybin-assisted therapy significantly reduced anxiety, depression, and demoralization in cancer patients — with effects sustained at six-month and five-year follow-ups, an almost unheard-of durability for a single-session or two-session intervention.
Addiction
Preliminary research suggests psilocybin may help interrupt addictive patterns for alcohol and tobacco use. A 2022 double-blind randomized controlled trial published in JAMA Psychiatry found that psilocybin-assisted therapy significantly reduced heavy drinking days compared to diphenhydramine (the active placebo). Earlier open-label studies at Johns Hopkins reported an 80% abstinence rate from tobacco at six months — outcomes that compare favorably to any existing smoking cessation intervention.
PTSD and Trauma
While MDMA-assisted therapy has more research behind it for PTSD specifically, psilocybin’s mechanism — reducing default mode network activity, increasing neuroplasticity, and facilitating emotional processing — suggests potential applicability to trauma. Research is ongoing.
The science is promising, but it is not settled. Psilocybin therapy is not a cure, and it is not appropriate for everyone. Screening, preparation, and integration are essential components of safe, effective use.
How Does Psilocybin Work in the Brain?
Psilocybin works primarily by binding to serotonin 2A (5-HT2A) receptors, particularly in the prefrontal cortex. This produces a cascade of effects that researchers believe are central to its therapeutic potential:
Reduced Default Mode Network Activity
The default mode network (DMN) is a collection of brain regions associated with self-referential thinking — the constant mental chatter about the past, the future, and our sense of self. In depression and anxiety, the DMN tends to be overactive and rigid. Psilocybin temporarily quiets the DMN, which many patients describe as a sense of liberation from rumination and a feeling of expanded perspective.
Increased Neuroplasticity
Studies using neuroimaging and animal models suggest that psilocybin promotes the growth of new synaptic connections and may increase BDNF (brain-derived neurotrophic factor). This “window of plasticity” following a psilocybin experience may be one reason why integration therapy — done in the days and weeks after the experience — is so important. The brain appears more malleable, more open to new patterns of thinking and relating.
Emotional Processing
Psilocybin tends to reduce the amygdala’s reactivity to negative stimuli, which may help people approach previously avoided emotional material with less fear. Patients commonly report being able to revisit difficult memories or feelings with a sense of compassionate distance — as if watching their own story from a new vantage point.
The Mystical Experience
One of the more unexpected findings in psilocybin research is that the intensity of a “mystical-type experience” — characterized by a sense of unity, sacredness, noetic quality, and transcendence — is predictive of positive therapeutic outcomes. This is not a fringe claim; it appears across multiple research sites and has been measured using validated instruments like the Mystical Experience Questionnaire. Researchers don’t fully understand why this is the case, but it has become an accepted part of the scientific literature on psilocybin.
What Is Psilocybin Therapy Like? A Session Overview
While specific protocols vary depending on the research setting or retreat context, most psilocybin-assisted therapy follows a similar arc. Here’s what a typical protocol looks like:
Phase 1: Preparation (2–4 Sessions)
Before any psilocybin is administered, you spend meaningful time with your therapist or therapeutic team. These sessions serve several purposes:
- Building trust and therapeutic alliance — essential for feeling safe during the experience
- Setting intentions — exploring what you hope to gain, what you’re ready to face
- Education — understanding what to expect physically and psychologically
- Screening — assessing for contraindications such as personal or family history of psychosis, current use of certain medications (especially lithium and SSRIs), or cardiovascular conditions
- Developing coping strategies — learning how to work with difficult moments during the experience
Phase 2: The Dosing Session
In research settings, dosing sessions are carefully controlled. You arrive at a comfortable, specially designed room — not a clinical-looking medical space — and ingest psilocybin in capsule form. Eye shades and carefully selected music are typically used to support an inward journey. One or two trained therapists are present throughout, offering support, grounding touch (with consent), or gentle verbal guidance if distress arises. Sessions last approximately six to eight hours.
The experience is different for everyone. Some people encounter vivid imagery, emotional release, or a profound sense of interconnectedness. Others experience confronting or uncomfortable material — what researchers call “challenging experiences” — that, with proper support, can still yield therapeutic benefit. This is why the therapeutic relationship and preparation work matter so much.
Phase 3: Integration (3–12 Sessions or More)
Integration is where much of the therapeutic work in psilocybin-assisted therapy Orlando happens. The psilocybin experience itself is catalytic — it loosens fixed patterns, brings material to the surface, opens new perspectives. Integration therapy helps you make meaning of what arose, translate insights into changes in how you live, relate, and understand yourself, and work through anything difficult or confusing that emerged during the experience.
Without integration, the benefits of a psilocybin-assisted therapy Orlando experience tend to be shorter-lived. With skilled integration support, research suggests that meaningful changes can persist for months and sometimes years.
Who Is a Good Candidate for Psilocybin-Assisted Therapy Orlando?
Psilocybin-assisted therapy Orlando is not for everyone. The following factors are generally considered when assessing appropriateness:
Conditions That May Benefit
- Treatment-resistant depression (not responding to two or more antidepressant trials)
- Major depressive disorder
- Anxiety disorders, including generalized anxiety and social anxiety
- PTSD and trauma-related conditions
- End-of-life anxiety and existential distress
- Addiction (alcohol, tobacco, and other substance use disorders)
- OCD (emerging research)
Contraindications and Cautions
Psilocybin is not appropriate for individuals with:
- Personal or family history of schizophrenia, psychosis, or bipolar I disorder
- Active suicidal ideation with intent or plan
- Current use of lithium (risk of seizure) or MAOIs
- Certain cardiovascular conditions
- Pregnancy
High doses of SSRIs may blunt the effects of psilocybin. This is an active area of discussion among researchers and clinicians, and decisions about medication adjustments should always be made carefully with a prescribing physician.
Psychological Readiness
Beyond clinical criteria, there’s the question of readiness. Psilocybin experiences can be profound and sometimes difficult. People who tend to do best are those who:
- Have a stable enough foundation to tolerate emotional disruption
- Are motivated to engage in the preparation and integration process, not just the experience itself
- Have reasonable expectations — understanding this is a therapeutic tool, not a magic solution
- Are working with qualified, ethical practitioners
The Legal Landscape in Florida (2026)
When exploring psilocybin-assisted therapy Orlando options, the legal landscape is one of the most common questions we receive, and it’s important to be clear.
At the federal level, psilocybin remains a Schedule I controlled substance under the Controlled Substances Act. This means it is illegal to manufacture, distribute, or possess psilocybin outside of DEA-authorized research settings.
At the state level, Florida does not currently have a therapeutic psilocybin framework. Oregon (Measure 109) and Colorado (Proposition 122) have passed legislation creating regulated therapeutic psilocybin access, but these systems are in early stages and are not available to Florida residents without traveling to those states. Several other states have decriminalization measures at the city level, but this is distinct from legal therapeutic access.
Some Florida residents travel to Oregon, Colorado, Jamaica, the Netherlands, or Mexico for legal psilocybin experiences in retreat settings. If you are considering this, preparation and integration support from a skilled therapist before and after the experience can significantly improve outcomes and safety.
What Achieve Growth Therapy Offers
Our clinicians are trained in psychedelic-assisted therapy frameworks and harm reduction approaches. Within the bounds of Florida law, we offer:
- Preparation sessions for clients considering a legal psilocybin-assisted therapy experience (travel retreat, clinical trial, etc.)
- Integration therapy following a psilocybin experience
- Harm reduction counseling
- Ketamine-assisted therapy (where legal and clinically appropriate — ketamine is the one psychedelic currently legal for medical use)
- Psychedelic-informed therapy — applying insights from psychedelic research to conventional therapy modalities
We believe that the therapeutic container is what makes psilocybin experiences healing rather than simply intense. Our work is to help you make the most of whatever journey you are on.
How to Find a Qualified Psilocybin-Assisted Therapy Provider in Orlando
Not everyone offering psilocybin-assisted therapy in Orlando calling themselves a “psychedelic therapist” or “integration coach” has appropriate training, ethical grounding, or clinical credentials. Here are the questions to ask before working with any provider:
- Are they a licensed mental health professional (LMHC, LCSW, licensed psychologist, or MD/DO)?
- Have they completed specialized training in psychedelic-assisted therapy (e.g., MAPS training, Fluence, CIIS, or similar programs)?
- Do they have malpractice insurance and a clear ethics framework?
- Are they transparent about what is legal in Florida and what is not?
- Do they offer a thorough intake and screening process?
- Do they prioritize integration, not just the experience itself?
Be cautious of practitioners who suggest they can administer psilocybin in Florida outside of a clinical trial, who minimize risks, or who rush the preparation process. The therapeutic container is everything in this work.
Psilocybin-Assisted Therapy Integration in Orlando: Making the Experience Last
Even if you’ve already had a psilocybin experience — in a retreat, on your own, or elsewhere — psilocybin-assisted therapy Orlando integration support can help you process and extend what arose.
Integration is not debriefing. It is an ongoing therapeutic process that involves:
- Meaning-making — exploring the themes, symbols, and feelings that emerged and what they might mean for your life
- Somatic integration — working with the body, not just the mind, to process what was activated
- Relational integration — how insights from the experience might change how you show up in relationships
- Behavioral integration — translating insights into new habits, boundaries, or life choices
- Spiritual or existential integration — making sense of any transcendent, mystical, or unusual experiences
Many people find that the most transformative growth from psilocybin-assisted therapy Orlando happens not during the experience itself, but in the months of thoughtful integration work that follow.
Frequently Asked Questions
Is psilocybin therapy safe?
Physiologically, psilocybin has one of the most favorable safety profiles of any psychoactive substance. It is non-addictive, has low toxicity, and does not damage organs. The primary risks are psychological: difficult experiences, the rare triggering of latent psychiatric conditions in high-risk individuals, and misuse without appropriate support. This is why screening, preparation, and professional support are essential for anyone considering psilocybin-assisted therapy in Orlando or anywhere else.
How long do the effects of psilocybin last?
The acute experience typically lasts four to six hours. The therapeutic benefits, when combined with integration work, can persist for months and sometimes years. This is one of the more remarkable aspects of the research — a small number of sessions producing durable change.
Will my insurance cover psilocybin therapy?
Currently, no. Because psilocybin remains a Schedule I substance federally, it is not covered by insurance. Integration therapy sessions with a licensed mental health professional, however, may be eligible for coverage depending on your plan and the diagnosis codes used. We recommend checking with your insurance provider.
Can I do psilocybin therapy if I’m on antidepressants?
This is a nuanced question best answered in consultation with your prescribing physician and a psilocybin-informed clinician. SSRIs may blunt the acute effects of psilocybin. Abruptly stopping antidepressants is not recommended and can itself cause significant symptoms. Any medication changes should be managed carefully and collaboratively.
What if I have a bad trip?
Challenging experiences during psilocybin sessions — what some call “difficult trips” — are fairly common and are not necessarily therapeutic failures. In research protocols, they are often associated with meaningful therapeutic breakthroughs when well-supported. The key factors are: being in a safe physical environment, having a trusted, skilled therapist present, having done sufficient preparation to develop coping skills, and approaching the experience with acceptance rather than resistance.
Is there a clinical trial for psilocybin near Orlando?
Clinical trials for psilocybin-assisted therapy are ongoing across the United States. The best place to find current trials is ClinicalTrials.gov. Search for “psilocybin” and filter by location near Orlando. Availability changes frequently as trials open and close.
Ready to Learn More? We’re Here to Help.
Psilocybin-assisted therapy in Orlando is a rapidly evolving field, and it can feel overwhelming to navigate on your own. Whether you are curious about whether this approach might be right for you, looking for integration support after a recent experience, or simply wanting to talk with a clinician who understands the research, Achieve Growth Therapy is here. We also offer therapy for depression, anxiety therapy, trauma-informed therapy, and telehealth therapy across Florida.
Our therapists in Orlando offer compassionate, evidence-informed care for adults navigating depression, anxiety, trauma, and major life transitions. We take the science seriously, and we take your wellbeing seriously.
Schedule a free 15-minute consultation today.
Call us at [PHONE] or use the contact form on our website. Telehealth appointments are available for clients throughout Florida.